Although these studies provided evidence to separate EBV+ NT/NKCL from ENKTL and PTCL-NOS, the JAK/STAT signal pathway mutation profile overlaps with that of ALK-negative ALCL [20]. This evidence concerns the gene SOAT1 and mature T-cell and NK-cell non-Hodgkin lymphoma.